Expert-to-expert video podcast series designed for time-pressured clinicians on advances in the management of HER2-positive NSCLC.
Episode 1 is on HER2 biomarker testing in practice. Looking at the guidelines, the focus will be on detection, overexpression and amplification, providing practical steps for testing and integration into clinical workflows, in the context of real-world barriers.
Time duration 20 mins.
Episode 2 is about the practical considerations for implementation of the therapies, including integrating HER2-targeted ADCs into treatment pathways, navigating real-world factors, monitoring and management of common and unique toxicities, and the role of multidisciplinary coordination.
Time duration 20 mins.
The third and final episode will look at the future directions in HER2-positive NSCLC; ongoing clinical trials, emerging novel agents in development, the role of ADCs in first-line management of NSCLC with expert perspectives on what lies ahead.
Time duration is 20 mins.
